PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10455328-8	1999	At the hD2 and hD3 dopamine receptors all the compounds tested were full agonists as compared to quinpirole.	Quinpirole	97-107	iodothyronine deiodinase 3	Homo sapiens	15-18	
17672446-7	2007	In addition, while all the derivatives with an olefinic linker were antagonists, in quinpirole-stimulated mitogenesis at hD3 receptors, several of the hydroxybutyl-linked analogues (16, 17, 21) showed partial agonist activity.	Quinpirole	84-94	iodothyronine deiodinase 3	Homo sapiens	121-124	
10431754-8	1999	In comparison, the dopamine receptor agonist, (-)quinpirole, acted as a partial agonist at hD3 and hD4 sites (Emax = 67.4% and 66.3%, respectively) but surpassed the efficacy of dopamine at hD2 receptors (Emax = 132%).	Quinpirole	49-59	iodothyronine deiodinase 3	Homo sapiens	91-94